$1B+
RAISED WITH OUR SUPPORT
by our clients across the science and technology sectors. We understand what investors expect because our founder sits on the other side of that table.
01
Who We Are
Most life sciences marketing agencies position around execution: content, campaigns, websites. The larger shops chase big pharma budgets. The smaller boutiques compete on price for deliverables.
HTG occupies a different position entirely: the intersection of commercialization strategy and marketing execution for earlier-stage and mid-stage science companies. Every engagement starts with strategy. The marketing work is always downstream of the commercial objective—closing a funding round, launching into a new indication, building a sales pipeline, or earning credibility with a technical buyer audience.
02
Why High
Touch Group
125+
SCIENCE COMPANIES SERVED
across diagnostics, medtech, biotech, advanced manufacturing, and climate tech.
~12
CLIENTS PER YEAR, BY DESIGN
Depth depends on knowing each client’s science, market, and competitive position in detail.
$21M
FROM A SINGLE 6-MONTH CAMPAIGN
in attributed revenue for a commercial-stage client entering new market segments.
03
Working With
Established
Companies
Some of our clients have large, sophisticated internal marketing teams. They work with HTG because we can add specialized expertise, capacity, and execution speed where they need it: scientific conferences, market intelligence, product launch campaigns, KOL programs, technical content, sales enablement, and other high-value commercial programs.
When a strong internal team is in place, we work with it. We are not there to create unnecessary overlap or displace people who are doing good work. We take on the work that sits outside the team’s bandwidth or specialization, and we integrate closely enough that the work feels like it came from inside the company.
Other companies need something different. A small or changing team may ask us to take responsibility for several marketing functions, or to operate most of the function on its behalf. We can do that too.
The model follows the company: from specialized support for an established team to broader operating responsibility when leadership needs it.
04
Our Network
We have established relationships with the diagnostics, medtech, and biotech trade press: 360Dx, FierceBiotech, GenomeWeb, MedTech Dive. We know the conferences where your buyers and investors gather. We know the investor community active in this space. We don’t understand your market from the outside. We’re connected to it.
05
Our Team
Our account strategists are former research program PIs, scientific business development managers, and product launch specialists who have worked with venture capital firms, private foundations, and federal agencies. Our writers hold advanced degrees in the sciences. Our market intelligence team conducts the competitive analysis and buyer research that grounds every strategy. We don’t need you to explain what a lateral flow assay is, what a 510(k) submission means for your launch timeline, or why your Series A pitch has to land differently than your Series B. We already know. That’s time back in your day and depth you can’t hire for at most agencies.
06 ELIZABETH CHABE, CEO
About
Elizabeth
Elizabeth Chabe (MBA) is the founder and CEO of High Touch Group and the author of The Giant’s Ladder: The Science Professional’s Blueprint for Marketing Success. She has spent her career at the intersection of science and commercial strategy, working with diagnostics and medtech founders, advising VC firms, and consulting for national health agencies. Since 2018, she has served as a governor-appointed director of the Maine Venture Fund, where she advises portfolio companies and helps direct strategic investments.
Get the BookThe definitive guide for scientists and founders who need to think like marketers.